Kristine Peterson
CIK 1508596 · last filed 2026-06-22
Kristine Peterson is a corporate insider who has filed 60 SEC Form 4 insider transactions across 8 companies since 2012. The most recent filing, for AVBP, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $91.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$91.7K
8
60
-$3.85M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVBP | Director | — | $29.98 | — | $0 | 3 | 2026-06-22 |
| IMCR | Director | — | $33.51 | — | $0 | 3 | 2026-05-28 |
| ENTA | Director | — | $12.61 | — | $0 | 10 | 2026-03-13 |
| ImmunoGen, Inc. (IMGN) Delisted | Director | 0 | $31.23 | $0 | -$578.0K | 16 | 2024-02-12 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Director | 0 | $2.23 | $0 | $0 | 9 | 2023-09-21 |
| AMRN | Director | 6,000 | $13.95 | $83.7K | -$3.27M | 12 | 2022-06-29 |
| EYPT | Director | 667 | $11.96 | $8.0K | $0 | 4 | 2020-03-03 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 1 | 2017-12-19 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2026-05-28 | IMCR | Grant (A) | — | $0 | EDGAR |
| 2026-03-13 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2025-05-19 | IMCR | Grant (A) | — | $0 | EDGAR |
| 2025-03-14 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | IMCR | Grant (A) | — | $0 | EDGAR |
| 2024-04-23 | AVBP | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | ENTA | Grant (A) | — | $0 | EDGAR |
| 2024-02-12 | ImmunoGen, Inc. (IMGN) Delisted | Disp (D) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.